Eco-Rx prepares a new round of efficacy testing for its RX 400.

NORTH MIAMI BEACH, FLORIDA -- (MARKET WIRE) – 03/07/2006 -- Eco-Rx (OTC: ERXX), producer of proprietary air purification products announces preparation for a new round of efficacy testing. A new testing protocol is being developed in conjunction with Northeast Testing Laboratories of Berlin, Connecticut. Northeast Testing, an EPA and FDA certified lab, has been involved with testing Eco-Rx technology for the past 5 years.

The new tests will simulate real world conditions measuring the removal (kill) of various organisms such as: Bacillus subtilis, Pseudomonas aeruginosa, Staphylococcus aureus, Klebsiella Pneumonia. Use of these organisms is consistent with prior testing protocols. In previous tests, the organisms were introduced into the air stream of the device. Samples of the purified air were collected from the exit air stream and the effectiveness (kill rate) was determined. For the new tests, a special chamber of known volume will be used. A very high concentration of test organisms will be introduced into the chamber. Air in the chamber will then be tested at specific intervals to ascertain the speed of killing the test organisms.

Very few companies marketing air purification devices make their test results available to their customers or the general public. Eco-Rx believes that a company must substantiate the claims made for its products. As such, current and future test results from Eco-Rx will available for review.

Disclaimer
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include expectations which involve risks and uncertainties that could cause actual results to differ materially from results expressed or implied by these statements. Factors that might cause or contribute to such differences include, but are not limited to: difficulties encountered in launching a new product, competition and receiving timely shipments from the manufacturer in China. Eco-Rx undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement.

back to News